Replies to post #247654 on Biotech Values

[DewDiligence]

TALS—>TRML (Tourmaline Bio) effective at Thursday’s open—concurrent with 1:10 reverse split, pursuant to previously announced reverse-merger:

https://www.globenewswire.com/news-release/2023/10/17/2761965/0/en/Talaris-Therapeutics-Announces-Stockholder-Approval-of-Merger-with-Tourmaline-Bio.html